<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sun, 12 Apr 2026 09:51:38 -0400--><rss version="2.0">
    <channel>
        <title>Immunovant, Inc. (IMVT) SEC Filings</title>
        <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/rss</link>
        <description>Immunovant, Inc. (IMVT) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_d6ae8ad1fc90c30ceeec0c8ff3e3b1be/immunovant/files/theme/images/logo-sm.jpg</url>
                <title>Immunovant, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001779707-26-000004/0001779707-26-000004.pdf</link>
                <pubDate>Fri, 10 Apr 26 16:06:46 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001779707-26-000004/0001779707-26-000004.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001973838-26-000004/0001973838-26-000004.pdf</link>
                <pubDate>Fri, 10 Apr 26 16:04:22 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001973838-26-000004/0001973838-26-000004.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001702969-26-000006/0001702969-26-000006.pdf</link>
                <pubDate>Fri, 10 Apr 26 16:03:51 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001702969-26-000006/0001702969-26-000006.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000052/0001764013-26-000052.pdf</link>
                <pubDate>Thu, 09 Apr 26 16:32:55 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000052/0001764013-26-000052.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000050/0001764013-26-000050.pdf</link>
                <pubDate>Thu, 09 Apr 26 16:29:14 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000050/0001764013-26-000050.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000048/0001764013-26-000048.pdf</link>
                <pubDate>Thu, 09 Apr 26 16:27:16 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000048/0001764013-26-000048.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000046/0001764013-26-000046.pdf</link>
                <pubDate>Thu, 09 Apr 26 16:25:50 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000046/0001764013-26-000046.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000044/0001764013-26-000044.pdf</link>
                <pubDate>Thu, 09 Apr 26 16:24:43 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000044/0001764013-26-000044.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000042/0001764013-26-000042.pdf</link>
                <pubDate>Thu, 09 Apr 26 16:23:29 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000042/0001764013-26-000042.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000040/0001764013-26-000040.pdf</link>
                <pubDate>Thu, 09 Apr 26 16:23:14 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000040/0001764013-26-000040.pdf</guid>
                                                                            </item>
            </channel>
</rss>